UnknownNot Applicable

Role of Contrast Enhanced Digital Mammography in Female Patients With Pathological Nipple Discharge

40 participantsStarted 2020-12

Plain-language summary

To evaluate the validity of contrast enhanced digital mammography in evaluation of pathological nipple discharge .

Who can participate

Age range20 Years – 80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: 1\_in diagnosis of female patients with pathological nipple discharge Exclusion Criteria: * 1\. Patients with renal failure or with raised renal chemistry 2-patients who are allergic to contrast 2. Pregnant women

What they're measuring

To correlate results of CEM with histopathology (TCNB,FNAC,surgical excision) in female patients with pathological nipple discharge .

Timeframe: Baseline

Trial details

NCT IDNCT04651257

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-09

Contact for this trial

Marwa Mohamed Mosaad

01002737790 Marweka6@gmail.com

View on ClinicalTrials.gov More Contrast Mammography in Pathological Nipple Discharge trials